{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:47:17Z","timestamp":1780465637808,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"German Federal Ministry of Education and Research","award":["FKZ 01GG0716 und 01GG717"],"award-info":[{"award-number":["FKZ 01GG0716 und 01GG717"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.intimp.2012.10.010","type":"journal-article","created":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T17:15:40Z","timestamp":1351098940000},"page":"722-728","source":"Crossref","is-referenced-by-count":15,"title":["Characterization of immunologically active drugs in a novel organotypic co-culture model of the human gut and whole blood"],"prefix":"10.1016","volume":"14","author":[{"given":"Michael","family":"Schmohl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Schneiderhan-Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Baur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Hefner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerburg M.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas O.","family":"Joos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Schmolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2012.10.010_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4331\/wjbc.v3.i4.73","article-title":"Pharmacokinetics and toxicology of therapeutic proteins: advances and challenges","volume":"3","author":"Vugmeyster","year":"2012","journal-title":"World J Biol Chem"},{"key":"10.1016\/j.intimp.2012.10.010_bb0010","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.copbio.2009.10.002","article-title":"Safety of biologics, lessons learnt from TGN1412","volume":"20","author":"Stebbings","year":"2009","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.intimp.2012.10.010_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17460441.2.7.935","article-title":"Functional drug candidate profiling using complex human organotypic cell culture models: a promising way to reduce clinical drug failure","volume":"2","author":"Schmolz","year":"2007","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.intimp.2012.10.010_bb0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10787-008-8007-x","article-title":"Human whole blood assay for rapid and routine testing of non-steroidal anti-inflammatory drugs (NSAIDs) on cyclo-oxygenase-2 activity","volume":"16","author":"Laufer","year":"2008","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2012.10.010_bb0025","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.4049\/jimmunol.179.5.3325","article-title":"\u201cCytokine storm\u201d in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics","volume":"179","author":"Stebbings","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.10.010_bb0030","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0016-5085(89)80072-1","article-title":"Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability","volume":"96","author":"Hidalgo","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2012.10.010_bb0035","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1053\/j.gastro.2005.12.015","article-title":"Probiotics and commensals reverse TNF-alpha- and IFN-gamma-induced dysfunction in human intestinal epithelial cells","volume":"130","author":"Resta-Lenert","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2012.10.010_bb0040","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1021\/js960110x","article-title":"HT29-MTX\/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro\u2013in vivo correlation with permeability data from rats and humans","volume":"85","author":"Walter","year":"1996","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.intimp.2012.10.010_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","article-title":"The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics","volume":"21","author":"Sambuy","year":"2005","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.intimp.2012.10.010_bb0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(00)00128-9","article-title":"Caco-2 monolayers in experimental and theoretical predictions of drug transport","volume":"46","author":"Artursson","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.intimp.2012.10.010_bb0060","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1080\/00498250802050880","article-title":"Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions","volume":"38","author":"Elsby","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.intimp.2012.10.010_bb0065","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/(SICI)1097-4652(199803)174:3<362::AID-JCP10>3.0.CO;2-B","article-title":"Caco-2 cells express a combination of colonocyte and enterocyte phenotypes","volume":"174","author":"Engle","year":"1998","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.intimp.2012.10.010_bb0070","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.4049\/jimmunol.178.7.4641","article-title":"IL-1beta causes an increase in intestinal epithelial tight junction permeability","volume":"178","author":"Al-Sadi","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.10.010_bb0075","doi-asserted-by":"crossref","first-page":"G422","DOI":"10.1152\/ajpgi.00412.2004","article-title":"Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression","volume":"288","author":"Ma","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.intimp.2012.10.010_bb0080","doi-asserted-by":"crossref","first-page":"G367","DOI":"10.1152\/ajpgi.00173.2003","article-title":"TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation","volume":"286","author":"Ma","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.intimp.2012.10.010_bb0085","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.1091\/mbc.E05-03-0193","article-title":"Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane","volume":"16","author":"Utech","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.intimp.2012.10.010_bb0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.med.51.1.289","article-title":"Role of cytokines in the pathogenesis of inflammatory bowel disease","volume":"51","author":"Papadakis","year":"2000","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.intimp.2012.10.010_bb0095","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.0105-2896.2005.00293.x","article-title":"Defects in mucosal immunity leading to Crohn's disease","volume":"206","author":"Cobrin","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.intimp.2012.10.010_bb0100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ibd.21403","article-title":"Importance of disrupted intestinal barrier in inflammatory bowel diseases","volume":"17","author":"Salim","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.intimp.2012.10.010_bb0105","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.4049\/jimmunol.166.3.1650","article-title":"Prostaglandin E2 up-regulates macrophage-derived chemokine production but suppresses IFN-inducible protein-10 production by APC","volume":"166","author":"Kuroda","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2012.10.010_bb0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/bdd.2510110311","article-title":"Pharmacokinetics and absolute bioavailability of ibuprofen after oral administration of ibuprofen lysine in man","volume":"11","author":"Martin","year":"1990","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.intimp.2012.10.010_bb0115","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2036.2007.03379.x","article-title":"Review article: appropriate use of corticosteroids in Crohn's disease","volume":"26","author":"Irving","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.intimp.2012.10.010_bb0120","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMra040226","article-title":"Therapeutic strategies for rheumatoid arthritis","volume":"350","author":"O'Dell","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2012.10.010_bb0125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.coph.2010.02.001","article-title":"Pharmacology of glucocorticoids in rheumatoid arthritis","volume":"10","author":"Spies","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.intimp.2012.10.010_bb0130","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3748\/wjg.v12.i10.1509","article-title":"Exacerbation of inflammatory bowel disease by nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors: fact or fiction?","volume":"12","author":"Guslandi","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.intimp.2012.10.010_bb0135","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00228-009-0719-3","article-title":"Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?","volume":"65","author":"Kefalakes","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.intimp.2012.10.010_bb0140","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3181\/00379727-214-44099","article-title":"Intestinal epithelial barrier dysfunction in Crohn's disease","volume":"214","author":"Ma","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.intimp.2012.10.010_bb0145","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1097\/01.mcg.0000155553.28348.fc","article-title":"Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators","volume":"39","author":"Korzenik","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.intimp.2012.10.010_bb0150","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/gut.31.6.686","article-title":"Role of interleukin 1 in inflammatory bowel disease\u2014enhanced production during active disease","volume":"31","author":"Ligumsky","year":"1990","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2012.10.010_bb0155","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s002689900401","article-title":"Cytokines in inflammatory bowel disease","volume":"22","author":"Rogler","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.intimp.2012.10.010_bb0160","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00384-003-0554-4","article-title":"Cytokine\/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease","volume":"19","author":"Stallmach","year":"2004","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.intimp.2012.10.010_bb0165","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3748\/wjg.v13.i13.1962","article-title":"Lactobacillus plantarum inhibits epithelial barrier dysfunction and interleukin-8 secretion induced by tumor necrosis factor-alpha","volume":"13","author":"Ko","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.intimp.2012.10.010_bb0170","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00024382-200303000-00006","article-title":"Proinflammatory cytokines cause NO*-dependent and -independent changes in expression and localization of tight junction proteins in intestinal epithelial cells","volume":"19","author":"Han","year":"2003","journal-title":"Shock"},{"issue":"3","key":"10.1016\/j.intimp.2012.10.010_bb0205","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00384-009-0847-3","article-title":"Influence of NFkappaB inhibitors on IL-1beta-induced chemokine CXCL8 and -10 expression levels in intestinal epithelial cell lines: glucocorticoid ineffectiveness and paradoxical effect of PDTC","volume":"25","author":"Sunil","year":"2010","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.intimp.2012.10.010_bb0180","first-page":"85","article-title":"Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide","volume":"81","author":"Schuerer-Maly","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2012.10.010_bb0185","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/gut.42.2.208","article-title":"Interferon gamma induces differential upregulation of alpha and beta chemokine secretion in colonic epithelial cell lines","volume":"42","author":"Warhurst","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2012.10.010_bb0190","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00384-007-0396-6","article-title":"NF-kappaB-dependent synergistic regulation of CXCL10 gene expression by IL-1beta and IFN-gamma in human intestinal epithelial cell lines","volume":"23","author":"Yeruva","year":"2008","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.intimp.2012.10.010_bb0195","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/BF01300378","article-title":"Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease","volume":"37","author":"Stevens","year":"1992","journal-title":"Dig Dis Sci"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576912003025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576912003025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T23:22:04Z","timestamp":1542669724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576912003025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1567576912003025"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2012.10.010","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}